U.S. flag

An official website of the United States government

NM_004287.5(GOSR2):c.22dup (p.Thr8fs) AND Muscular dystrophy

Germline classification:
not provided (1 submission)
Review status:
no classification provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000509134.1

Allele description [Variation Report for NM_004287.5(GOSR2):c.22dup (p.Thr8fs)]

NM_004287.5(GOSR2):c.22dup (p.Thr8fs)

Genes:
GOSR2:golgi SNAP receptor complex member 2 [Gene - OMIM - HGNC]
LRRC37A2:leucine rich repeat containing 37 member A2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
17q21.32
Genomic location:
Preferred name:
NM_004287.5(GOSR2):c.22dup (p.Thr8fs)
Other names:
p.Thr8Asnfs*54
HGVS:
  • NC_000017.11:g.46923214dup
  • NG_031806.2:g.5095dup
  • NM_001012511.3:c.22dup
  • NM_001321133.2:c.22dup
  • NM_001321134.2:c.-81dup
  • NM_001330252.2:c.22dup
  • NM_001353114.2:c.22dup
  • NM_001353115.2:c.22dup
  • NM_001353116.2:c.22dup
  • NM_001363851.2:c.-444dup
  • NM_004287.4:c.22dupA
  • NM_004287.5:c.22dupMANE SELECT
  • NM_004287.5:c.22dup
  • NM_054022.4:c.22dup
  • NP_001012529.1:p.Thr8fs
  • NP_001308062.1:p.Thr8fs
  • NP_001317181.1:p.Thr8fs
  • NP_001340043.1:p.Thr8fs
  • NP_001340044.1:p.Thr8fs
  • NP_001340045.1:p.Thr8fs
  • NP_004278.2:p.Thr8fs
  • NP_473363.1:p.Thr8fs
  • NC_000017.10:g.45000577_45000578insA
  • NC_000017.10:g.45000580dup
  • NM_004287.3:c.22dupA
  • NM_004287.4:c.22dup
  • NR_148349.2:n.55dup
  • NR_148350.2:n.55dup
  • NR_148351.2:n.55dup
Protein change:
T8fs
Links:
dbSNP: rs746855352
NCBI 1000 Genomes Browser:
rs746855352
Molecular consequence:
  • NM_001321134.2:c.-81dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001363851.2:c.-444dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001012511.3:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001321133.2:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001330252.2:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001353114.2:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001353115.2:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001353116.2:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_004287.5:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_054022.4:c.22dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_148349.2:n.55dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148350.2:n.55dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148351.2:n.55dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Muscular dystrophy
Identifiers:
MONDO: MONDO:0020121; MeSH: D009136; MedGen: C0026850; Human Phenotype Ontology: HP:0003560

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000607039GenomeConnect, ClinGen
no classification provided
not providedmaternalphenotyping only

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalunknownnot providednot providednot providednot providednot providedphenotyping only

Details of each submission

From GenomeConnect, ClinGen, SCV000607039.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedphenotyping onlynot provided

Description

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalunknownnot providednot providedvalidationnot providednot providednot providednot provided

Last Updated: Mar 16, 2024